Pharmaceuticals

Reports by Industry

Research Reports in Pharmaceuticals

Retinal Vein Occlusion – Drug Pipeline Landscape, 2023
February, 2023

Retinal Vein Occlusion is blockage of one of the retinal veins, which are blood vessels that carry deoxygenated blood back to the heart. Central retinal vein occlusion (CRVO) is a blockage in the main vein of your retina and Branch… Read More
Single User License
Buy Now

COVID-19 Detection Kits Market
February, 2023

The global COVID-19 Detection Kits Market was valued at USD 30.2 Billion in 2022 and it is anticipated to grow up to USD 2.2 Billion by 2032, at a CAGR of -23.2 % during the forecast period. The novel coronavirus… Read More
Single User License
Buy Now

Compounding Pharmacies Market
February, 2023

The global Compounding Pharmacies Market was valued at 11.2 billion in 2022 and it is anticipated to grow up to USD 20.8 billion by 2032, at a CAGR of 6.4% during the forecast period. An Compounding Pharmacies is a type… Read More
Single User License
Buy Now

Chronic Kidney Disease – Drug Pipeline Landscape, 2023
February, 2023

Chronic kidney disease is the slow loss of kidney function over time. The kidneys filter wastes and excess fluids from the blood. Advanced chronic kidney disease can cause dangerous levels of fluid, electrolytes, and wastes to build up in the… Read More
Single User License
Buy Now

Biopharmaceutical CMO Market
February, 2023

A Contract Manufacturing Organization (CMO), also known as a Biopharmaceutical CMO, is a company that provides manufacturing and other services to the pharmaceutical and biotechnology industries. CMOs are an important part of the pharmaceutical supply chain, and they play a… Read More
Single User License
Buy Now

Generalized Anxiety Disorder (GAD) – Drug Pipeline Landscape, 2023
February, 2023

Generalized Anxiety Disorder (GAD) is a mental health condition, characterized by excessive, frequent and unrealistic worry about everyday things. People with Generalized Anxiety Disorder anticipates disaster and overly concerned about health, family, work, money or other issues when there is… Read More
Single User License
Buy Now

Outpatient Oncology Infusion Market
February, 2023

The global Outpatient Oncology Infusion Market was valued at 63.6 billion in 2022 and it is anticipated to grow up to USD 205.3 billion by 2032, at a CAGR of 12.4% during the forecast period. The outpatient oncology infusion centers… Read More
Single User License
Buy Now

Hypercholesterolemia – Drug Pipeline Landscape, 2023
February, 2023

Hypercholesterolemia is a lipid disorder also known as high cholesterol. The presence of high plasma cholesterol levels with normal plasma triglycerides results in a rise in cholesterol and apolipoprotein B (apoB)-rich lipoproteins (LDL). Both genetic and environmental factors contribute to… Read More
Single User License
Buy Now

Hepatitis A – Drug Pipeline Landscape, 2023
February, 2023

Hepatitis A is an inflammation of the liver caused by the hepatitis A virus (HAV). The virus is primarily spread when an uninfected (and unvaccinated) person ingests food or water that is contaminated with the faeces of an infected person.… Read More
Single User License
Buy Now

Glioblastoma Multiforme (GBM) – Drug Pipeline Landscape, 2023
February, 2023

Glioblastoma Multiforme (GBM) is a fast-growing and most common type of cancer that starts in the brain, a central nervous system tumor that forms from supportive (glial) tissue of the brain and spinal cord, usually occurs in adults and affects… Read More
Single User License
Buy Now

Microbial Identification Market
February, 2023

The global Microbial Identification Market was valued at USD 4.1 Billion in 2022 and it is anticipated to grow up to USD 13.3 Billion by 2032, at a CAGR of 12.5% during the forecast period. Microbial Identification is used to… Read More
Single User License
Buy Now

Neurological Biomarker Market
February, 2023

The global Neurological Biomarkers Market was valued at USD 6.8 Billion in 2022 and it is anticipated to grow up to USD 28.6 Billion by 2032, at a CAGR of 15.4% during the forecast period. Neurological Biomarkers is used to… Read More
Single User License
Buy Now

Gastrointestinal Stromal Tumors (GIST) – Drug Pipeline Landscape, 2023
February, 2023

Gastrointestinal Stromal Tumor (GIST) is a rare tumor that occur when cells become abnormal and grow out of control in the tissues of the gastrointestinal tract, from the esophagus to the anus. Gastrointestinal Stromal Tumor most often occurs within the… Read More
Single User License
Buy Now

Next Generation Sequencing Market
February, 2023

The global Next-generation Sequencing Market was valued at 5.4 billion in 2022 and it is anticipated to grow up to USD 18.7 billion by 2032, at a CAGR of 13.2% during the forecast period. Next-generation sequencing (NGS) is a type… Read More
Single User License
Buy Now

NGS-Based RNA-Sequencing Market 
February, 2023

The global NGS-based RNA Sequencing Market was valued at USD 2.8 Billion in 2022 and it is anticipated to grow up to USD 21.3 Billion by 2032, at a CAGR of 22.5% during the forecast period. NGS-based RNA Sequencing is… Read More
Single User License
Buy Now

Peptic Ulcers – Drug Pipeline Landscape, 2023
February, 2023

Peptic ulcer disease (PUD) is a sore on the lining of the stomach, the first part of the small intestine, or the lower part of the esophagus that is due to the digestive action of pepsin and stomach acid. An… Read More
Single User License
Buy Now

Post-Traumatic Stress Disorder (PTSD) – Drug Pipeline Landscape, 2023
February, 2023

Post-Traumatic Stress Disorder is a mental health condition that’s triggered by either experiencing or observing a horrible event. People who have PTSD may feel stressed or frightened, even when they are not in danger. The main causes of post-traumatic stress… Read More
Single User License
Buy Now

Prenatal and Newborn Genetic Testing Market
February, 2023

The global Prenatal and New-born Genetic Testing Market was valued at USD 4.5 Billion in 2022 and it is anticipated to grow up to USD 20.9 Billion by 2032, at a CAGR of 16.6% during the forecast period. Prenatal testing… Read More
Single User License
Buy Now

Metagenomics Market 
February, 2023

The global Metagenomics Market was valued at USD 1.6 Billion in 2022 and it is anticipated to grow up to USD 6.3 Billion by 2032, at a CAGR of 14.7% during the forecast period. Metagenomics comprises studies that use sequencing… Read More
Single User License
Buy Now

Anaplastic Astrocytoma – Drug Pipeline Landscape, 2023
February, 2023

Anaplastic astrocytoma (AA) is a rare malignant brain tumor or grade III gliomas. This tumor arises from star shaped brain cells called astrocytes. Tumors that arise from glial tissue, including astrocytoma’s, are collectively referred as gliomas. Anaplastic astrocytoma occurs without… Read More
Single User License
Buy Now

Whole Exome Sequencing Market 
February, 2023

The global Whole Exome Sequencing Market was valued at USD 1.4 Billion in 2022 and it is anticipated to grow up to USD 7.4 Billion by 2032, at a CAGR of 18.1% during the forecast period. Exome sequencing is a… Read More
Single User License
Buy Now

Pancreatic Cancer – Drug Pipeline Landscape, 2023
February, 2023

Pancreatic cancer arises when cells in the pancreas begin to grow out in an abnormal form and form a tumor. Pancreatic cancer is classified into the following stages: resectable, borderline resectable, locally advanced, and metastatic. Depending on where the tumour… Read More
Single User License
Buy Now

Progressive Supranuclear Palsy – Drug Pipeline Landscape, 2023
February, 2023

Progressive Supranuclear Palsy is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech, and swallowing. Progressive supranuclear palsy typically begins in late middle age and worsens over time, with severe disability occurring within three to five… Read More
Single User License
Buy Now

Nucleic Acid Amplification Testing Market
February, 2023

The global Nucleic Acid Amplification Testing Market was valued at USD 7.3 Billion in 2022 and it is anticipated to grow up to USD 24.5 Billion by 2032, at a CAGR of 12.8% during the forecast period. A Nucleic Acid… Read More
Single User License
Buy Now

Sanger Sequencing Market
February, 2023

The global Sanger Sequencing Market was valued at USD 1.9 Billion in 2022 and it is anticipated to grow up to USD 13.4 Billion by 2032, at a CAGR of 21.4% during the forecast period. The Sanger technique of DNA… Read More
Single User License
Buy Now